Literature DB >> 29031430

Leadership line care rounds: Application of the engage, educate, execute, and evaluate improvement model for the prevention of central line-associated bloodstream infections in children with cancer.

Angie Owings1, JoBeth Graves2, Sherry Johnson2, Craig Gilliam1, Mike Gipson1, Hana Hakim3.   

Abstract

To prevent central line-associated bloodstream infections (CLABSIs), leadership line care rounds (LLCRs) used the engage, educate, execute, and evaluate improvement model to audit compliance, identify barriers and opportunities, empower patients and families, and engage leadership. Findings of excellence and improvement opportunities were communicated to unit staff and managers. LLCRs contributed to compliance with CLABSI prevention interventions.
Copyright © 2018 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CLABSI prevention; Leadership rounding; line care; pediatric oncology

Mesh:

Year:  2017        PMID: 29031430     DOI: 10.1016/j.ajic.2017.08.032

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  3 in total

Review 1.  Reducing Central Line Associated Bloodstream Infections (CLABSIs) by Reducing Central Line Days.

Authors:  Amber Shaye McElveen Beville; Diane Heipel; Ginger Vanhoozer; Pamela Bailey
Journal:  Curr Infect Dis Rep       Date:  2021-11-02       Impact factor: 3.725

2.  Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update.

Authors:  Niccolò Buetti; Jonas Marschall; Marci Drees; Mohamad G Fakih; Lynn Hadaway; Lisa L Maragakis; Elizabeth Monsees; Shannon Novosad; Naomi P O'Grady; Mark E Rupp; Joshua Wolf; Deborah Yokoe; Leonard A Mermel
Journal:  Infect Control Hosp Epidemiol       Date:  2022-04-19       Impact factor: 6.520

3.  Scope of a weekly infection control team rounding in an acute-care teaching hospital: a pilot study.

Authors:  Yeon Su Jeong; Jin Hwa Kim; Seungju Lee; So Young Lee; Sun Mi Oh; Eunjung Lee; Tae Hyong Kim; Se Yoon Park
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-15       Impact factor: 4.887

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.